[{"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-001", "question": "A term male newborn is admitted to the NICU for respiratory distress and hypotension. Pregnancy was complicated by severe polyhydramnios and decreased fetal movements. On exam at 2 hours of life, he is hypotonic with a weak cry, absent gag, poor respiratory effort, and bilateral club feet. Cranial nerve exam shows poor suck and facial diplegia. Deep tendon reflexes are absent. There is no hepatosplenomegaly or dysmorphic features. CK is normal, EMG shows decreased compound muscle action potentials with normal sensory responses, and nerve conduction velocities are normal. Maternal history is negative for myasthenia gravis, and the infant does not respond to edrophonium. Which of the following is the most likely diagnosis?", "options": ["Spinal muscular atrophy type 0 due to homozygous SMN1 deletion with no SMN2 copies", "Congenital myotonic dystrophy from maternal DMPK expansion with neonatal hypotonia", "Congenital myasthenic syndrome due to presynaptic choline acetyltransferase deficiency", "Neonatal critical illness polyneuropathy associated with perinatal sepsis and multiorgan failure", "Congenital myopathy due to ACTA1 mutation with nemaline rods on muscle biopsy"], "answer": "A", "answer_index": 0, "explanation": "Profound prenatal-onset hypotonia, areflexia, respiratory failure at birth, normal CK and normal sensory studies with reduced CMAPs is most consistent with spinal muscular atrophy type 0, the most severe SMA phenotype (often no or very few SMN2 copies). Congenital myotonic dystrophy typically shows maternal myotonia and myopathic EMG; congenital myasthenic syndromes usually have fatigable weakness and neuromuscular junction abnormalities; critical illness polyneuropathy requires significant systemic illness; ACTA1 nemaline myopathy usually shows myopathic EMG and often elevated CK.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V. Verdict: Correct best answer. Key stem clues: severe polyhydramnios/decreased fetal movements indicating prenatal onset; profound hypotonia with facial diplegia, areflexia, respiratory failure; normal CK; EMG showing reduced CMAPs with preserved SNAPs and normal conduction velocities—classic for motor neuron disease. These findings uniquely point to spinal muscular atrophy type 0. Options are well-differentiated: congenital myotonic dystrophy would show myopathic EMG; congenital myasthenic syndrome would be edrophonium-responsive and show decrement; critical illness polyneuropathy requires systemic illness and would affect sensory responses; ACTA1 myopathy would have myopathic EMG features. No logical contradictions or underspecification. Medical accuracy: The clinical presentation and electrophysiology are accurate for SMA type 0. Minor nuance: SMA type 0 is typically associated with one SMN2 copy, not zero copies—zero copies is extremely rare. This genotype detail in option A is slightly imprecise but does not undermine the core teaching point. Minimal fix: Revise option A to read '...with one SMN2 copy' or simply '...severe spinal muscular atrophy type 0.'\",\"medical_accuracy_score\":  \t\"4\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V. Verdict: Correct best answer. Key stem clues: severe polyhydramnios/decreased fetal movements indicating prenatal onset; profound hypotonia with facial diplegia, areflexia, respiratory failure; normal CK; EMG showing reduced CMAPs with preserved SNAPs and normal conduction velocities—classic for motor neuron disease. These findings uniquely point to spinal muscular atrophy type 0. Options are well-differentiated: congenital myotonic dystrophy would show myopathic EMG; congenital myasthenic syndrome would be edrophonium-responsive and show decrement; critical illness polyneuropathy requires systemic illness and would affect sensory responses; ACTA1 myopathy would have myopathic EMG features. No logical contradictions or underspecification. Medical accuracy: The clinical presentation and electrophysiology are accurate for SMA type 0. Minor nuance: SMA type 0 is typically associated with one SMN2 copy, not zero copies—zero copies is extremely rare. This genotype detail in option A is slightly imprecise but does not undermine the core teaching point. Minimal fix: Revise option A to read '...with one SMN2 copy' or simply '...severe spinal muscular atrophy type 0.'", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-002", "question": "A 7-year-old boy presents with 6 months of intermittent fevers, night sweats, and weight loss. Exam shows generalized lymphadenopathy and marked splenomegaly. CBC shows pancytopenia. Bone marrow aspirate reveals hypercellularity with dysplastic erythroid and myeloid precursors and 12% myeloblasts. Flow cytometry shows aberrant expression of CD56 and bright CD7 on myeloid blasts. Cytogenetics reveal a t(8;16)(p11;p13) translocation involving KAT6A (MOZ) and CREBBP, and there is diffuse histiocytic hemophagocytosis in the marrow. Which of the following is the most appropriate initial management strategy?", "options": ["Observation with serial CBCs because this cytogenetic abnormality is associated with spontaneous remission", "Immediate allogeneic hematopoietic stem cell transplantation in first remission without induction chemotherapy", "AML-type intensive induction chemotherapy followed by high-dose cytarabine consolidation", "ALL-type induction followed by maintenance therapy due to frequent lymphoid involvement", "HLH-directed immunochemotherapy (etoposide, dexamethasone) alone given the hemophagocytic features"], "answer": "C", "answer_index": 2, "explanation": "t(8;16)(p11;p13) KAT6A-CREBBP is a high-risk AML subtype often with hemophagocytosis and poor prognosis, treated with intensive AML-style induction and consolidation; many centers consider transplant based on response and donor availability. Observation is inappropriate due to aggressive biology, and HLH-directed therapy alone will not control the leukemia. ALL-type regimens are not indicated for a clearly myeloid leukemia.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: The keyed answer C is the correct best choice. Key stem clues: 7‑year‑old with systemic symptoms, pancytopenia, marked splenomegaly, hypercellular marrow with dysplastic erythroid and myeloid precursors, 12 % myeloblasts, flow cytometry showing aberrant CD56 and bright CD7 on myeloid blasts, cytogenetics showing t(8;16)(p11;p13) KAT6A‑CREBBP translocation, and diffuse hemophagocytosis. These findings define a rare, high‑risk AML subtype that presents with HLH‑like features. The standard of care is intensive AML‑type induction chemotherapy (e.g., cytarabine/anthracycline) followed by consolidation; transplantation is considered based on response. Observation (A) is unsafe, immediate transplant without induction (B) is not standard, ALL‑type therapy (D) is inappropriate for a myeloid disease, and HLH‑directed therapy alone (E) would not eradicate the leukemia. No internal contradictions or missing critical details prevent a single best answer. Medical accuracy: The item reflects current pediatric AML management and the recognized poor prognosis of t(8;16) AML with hemophagocytosis. No factual errors. Minimal fix: None required.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer C is the correct best choice. Key stem clues: 7‑year‑old with systemic symptoms, pancytopenia, marked splenomegaly, hypercellular marrow with dysplastic erythroid and myeloid precursors, 12 % myeloblasts, flow cytometry showing aberrant CD56 and bright CD7 on myeloid blasts, cytogenetics showing t(8;16)(p11;p13) KAT6A‑CREBBP translocation, and diffuse hemophagocytosis. These findings define a rare, high‑risk AML subtype that presents with HLH‑like features. The standard of care is intensive AML‑type induction chemotherapy (e.g., cytarabine/anthracycline) followed by consolidation; transplantation is considered based on response. Observation (A) is unsafe, immediate transplant without induction (B) is not standard, ALL‑type therapy (D) is inappropriate for a myeloid disease, and HLH‑directed therapy alone (E) would not eradicate the leukemia. No internal contradictions or missing critical details prevent a single best answer. Medical accuracy: The item reflects current pediatric AML management and the recognized poor prognosis of t(8;16) AML with hemophagocytosis. No factual errors. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-003", "question": "A 4-year-old girl with newly diagnosed steroid-sensitive nephrotic syndrome starts high-dose prednisone 2 mg/kg/day. Baseline blood pressure and renal function were normal. After 3 weeks she achieves complete remission of proteinuria, but blood pressure is now consistently at the 98th percentile systolic and 99th percentile diastolic for age/height. Labs: normal electrolytes, creatinine 0.3 mg/dL, albumin 3.5 g/dL, and a normal echocardiogram. She has no headaches or visual changes. Which of the following is the most appropriate next step in management of her hypertension?", "options": ["Initiate an ACE inhibitor and maintain the current steroid dose until 6 weeks are completed", "Switch from daily to alternate-day prednisone dosing immediately and start a calcium channel blocker", "Begin a low-dose thiazide diuretic while continuing full-dose prednisone and sodium restriction", "Add tacrolimus and rapidly taper prednisone over 5 days while observing blood pressure", "Discontinue prednisone abruptly and monitor for adrenal insufficiency while starting an ARB"], "answer": "B", "answer_index": 1, "explanation": "In steroid-sensitive nephrotic syndrome with early remission and steroid-induced hypertension, the recommended approach is early transition to alternate-day prednisone while treating hypertension with an agent such as a calcium channel blocker; this reduces steroid toxicity without compromising remission. Abrupt discontinuation risks disease relapse and adrenal suppression, and ACEi/ARB are less favored for primary BP control with normal renal function and no persistent proteinuria.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": The question asks for the most appropriate next step in managing hypertension that developed during high-dose prednisone therapy for steroid-sensitive nephrotic syndrome (SSNS) after achieving remission. Key clues: 4-year-old, SSNS, high-dose prednisone 2 mg/kg/day, remission at 3 weeks, new severe hypertension (98th–99th percentile), normal labs and echo, no hypertensive symptoms. The stem implies steroid-induced hypertension in a patient who has responded to therapy. The keyed answer (B) proposes switching to alternate-day prednisone and starting a calcium channel blocker (CCB). This aligns with pediatric nephrology practice to minimize steroid toxicity while maintaining remission. However, the stem does not specify the exact duration of the initial daily steroid course (e.g., 4 weeks vs 6 weeks) or whether early alternate-day conversion is acceptable at 3 weeks. Some protocols require 4–6 weeks of daily steroids before alternate-day taper. The lack of this detail makes the timing ambiguous and could render the best answer underspecified. Option A (ACE inhibitor) is less favored in SSNS without persistent proteinuria and may be less effective for steroid-induced hypertension. Option C (thiazide) is reasonable but less preferred than CCB for steroid-induced hypertension in children. Option D (add tacrolimus and rapid taper) is inappropriate this early. Option E (abrupt discontinuation) is unsafe. The keyed answer is defensible if one assumes that early alternate-day conversion at 3 weeks is permissible, but this is not universally standardized. The item is therefore underspecified (U) because the optimal timing of steroid taper is not stated, and different centers may wait longer before switching to alternate-day dosing. The medical content is accurate and reflects current pediatric nephrology consensus on minimizing steroid toxicity. Minor nuance: the rationale correctly notes ACEi/ARB are less favored for primary BP control here.\",\"logical_false_reason\":\"U\",\"logical_validity\":false,\"medical_accuracy_score\":\"4\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": The question asks for the most appropriate next step in managing hypertension that developed during high-dose prednisone therapy for steroid-sensitive nephrotic syndrome (SSNS) after achieving remission. Key clues: 4-year-old, SSNS, high-dose prednisone 2 mg/kg/day, remission at 3 weeks, new severe hypertension (98th–99th percentile), normal labs and echo, no hypertensive symptoms. The stem implies steroid-induced hypertension in a patient who has responded to therapy. The keyed answer (B) proposes switching to alternate-day prednisone and starting a calcium channel blocker (CCB). This aligns with pediatric nephrology practice to minimize steroid toxicity while maintaining remission. However, the stem does not specify the exact duration of the initial daily steroid course (e.g., 4 weeks vs 6 weeks) or whether early alternate-day conversion is acceptable at 3 weeks. Some protocols require 4–6 weeks of daily steroids before alternate-day taper. The lack of this detail makes the timing ambiguous and could render the best answer underspecified. Option A (ACE inhibitor) is less favored in SSNS without persistent proteinuria and may be less effective for steroid-induced hypertension. Option C (thiazide) is reasonable but less preferred than CCB for steroid-induced hypertension in children. Option D (add tacrolimus and rapid taper) is inappropriate this early. Option E (abrupt discontinuation) is unsafe. The keyed answer is defensible if one assumes that early alternate-day conversion at 3 weeks is permissible, but this is not universally standardized. The item is therefore underspecified (U) because the optimal timing of steroid taper is not stated, and different centers may wait longer before switching to alternate-day dosing. The medical content is accurate and reflects current pediatric nephrology consensus on minimizing steroid toxicity. Minor nuance: the rationale correctly notes ACEi/ARB are less favored for primary BP control here.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-004", "question": "A 13-year-old girl presents with 1 year of fatigue and exercise intolerance. She has short stature, sensorineural hearing loss, mild ptosis, and a maternal family history of early-onset diabetes and deafness. BMI is 18 kg/m². Random glucose is 230 mg/dL, HbA1c 8.1%. C-peptide is low-normal, and GAD65, IA-2, and ZnT8 antibodies are negative. Lactate is mildly elevated at baseline and rises disproportionately after minimal exercise. Which of the following is the most appropriate initial pharmacologic management of her hyperglycemia?", "options": ["High-dose metformin monotherapy titrated to maximum tolerated dose", "Immediate initiation of a basal-bolus insulin regimen", "Sulfonylurea monotherapy due to likely KATP channel mutation", "GLP-1 receptor agonist therapy to improve insulin secretion", "SGLT2 inhibitor added to lifestyle therapy to decrease renal glucose reabsorption"], "answer": "B", "answer_index": 1, "explanation": "This presentation is most consistent with mitochondrial diabetes (e.g., MIDD) in the context of multisystem mitochondrial disease, for which insulin is preferred due to β-cell failure and risk of lactic acidosis with metformin. Sulfonylureas are indicated in many KATP-channel MODY forms, not mitochondrial disease. GLP-1 agonists and SGLT2 inhibitors are not first-line in pediatric mitochondrial diabetes and have limited safety data in this context.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": The stem describes a 13-year-old girl with short stature, sensorineural hearing loss, ptosis, maternal family history of early-onset diabetes and deafness, low-normal C-peptide, negative islet autoantibodies, and a disproportionate lactate rise with exercise. This constellation strongly suggests mitochondrial diabetes (MIDD, most often due to the m.3243A>G mutation). The question asks for the most appropriate initial pharmacologic management of her hyperglycemia. In mitochondrial diabetes, β-cell function declines over time, and metformin is contraindicated because of the risk of lactic acidosis. Insulin is therefore the recommended therapy. The keyed answer (B) aligns with this standard: basal-bolus insulin is appropriate for a pediatric patient with HbA1c 8.1% and likely β-cell failure. Option A is unsafe (metformin contraindicated). Option C is incorrect because sulfonylureas are used in KATP-channel MODY, not mitochondrial disease. Options D and E lack pediatric safety data and are not first-line. The stem provides sufficient discriminators (family history, hearing loss, ptosis, lactate rise, low C-peptide) to support mitochondrial diabetes as the likely diagnosis and insulin as the best initial therapy. No internal contradictions or missing critical details prevent a unique best answer. The item is accurate and board-style appropriate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": The stem describes a 13-year-old girl with short stature, sensorineural hearing loss, ptosis, maternal family history of early-onset diabetes and deafness, low-normal C-peptide, negative islet autoantibodies, and a disproportionate lactate rise with exercise. This constellation strongly suggests mitochondrial diabetes (MIDD, most often due to the m.3243A>G mutation). The question asks for the most appropriate initial pharmacologic management of her hyperglycemia. In mitochondrial diabetes, β-cell function declines over time, and metformin is contraindicated because of the risk of lactic acidosis. Insulin is therefore the recommended therapy. The keyed answer (B) aligns with this standard: basal-bolus insulin is appropriate for a pediatric patient with HbA1c 8.1% and likely β-cell failure. Option A is unsafe (metformin contraindicated). Option C is incorrect because sulfonylureas are used in KATP-channel MODY, not mitochondrial disease. Options D and E lack pediatric safety data and are not first-line. The stem provides sufficient discriminators (family history, hearing loss, ptosis, lactate rise, low C-peptide) to support mitochondrial diabetes as the likely diagnosis and insulin as the best initial therapy. No internal contradictions or missing critical details prevent a unique best answer. The item is accurate and board-style appropriate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-005", "question": "A 35-year-old man is brought to the ED after being found agitated and confused. He was seen smoking an unknown substance in a glass pipe. Vitals: T 39.2°C, HR 148, BP 182/108, RR 26, SpO₂ 98% RA. Exam shows severe agitation, diaphoresis, vertical nystagmus, generalized hypertonia, and intermittent purposeless limb movements. Pupils are 5 mm and reactive. Labs show CK 5,200 U/L, Na 142 mEq/L, K 4.3 mEq/L, creatinine 1.1 mg/dL, and mild metabolic acidosis. Urine tox is pending. Which of the following is the most appropriate next step in management?", "options": ["Administer IV dantrolene and schedule cooled IV saline for suspected malignant hyperthermia", "Rapid sequence intubation with succinylcholine and etomidate to allow active external cooling", "High-dose IV benzodiazepines and active cooling while avoiding physical restraints", "IV cyproheptadine and discontinuation of serotonergic medications for serotonin syndrome", "Lorazepam and IV haloperidol for agitation control followed by CT head"], "answer": "C", "answer_index": 2, "explanation": "The vertical nystagmus, severe agitation, hypertonia, and hyperthermia after smoking suggest PCP or related dissociative intoxication; management centers on high-dose benzodiazepines and aggressive cooling while avoiding physical restraints that can worsen rhabdomyolysis. Dantrolene is for malignant hyperthermia/heat stroke; succinylcholine is contraindicated with rhabdomyolysis risk; cyproheptadine treats serotonin syndrome (typically with clonus and hyperreflexia); haloperidol in stimulant/dissociative toxicity increases risk of dystonia and thermoregulatory impairment.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V (Valid). Verdict: The keyed answer (C) is the correct best answer. The stem provides classic features of PCP intoxication: vertical nystagmus, severe agitation, hypertonia, hyperthermia after smoking, and rhabdomyolysis (CK 5,200). These findings distinguish PCP from serotonin syndrome (which would show hyperreflexia, clonus, and often a serotonergic drug exposure) and from malignant hyperthermia (anesthetic trigger). The answer C (high‑dose IV benzodiazepines, active cooling, avoid physical restraints) aligns with current emergency management of dissociative intoxication. Alternative options are clearly inferior: A (dantrolene) is for malignant hyperthermia; B (succinylcholine) is contraindicated with rhabdomyolysis; D (cyproheptadine) targets serotonin syndrome; E (haloperidol) risks dystonia and worsens thermoregulation. No internal contradictions exist, and the vignette supplies enough discriminatory detail to select a single best answer. The only minor omission is that fluid resuscitation for rhabdomyolysis is not listed, but this does not undermine the correctness of C as the immediate next step. No medical inaccuracies are present. Minimal fix: none required.\",\"logical_false_reason\":\"T\",\"logical_validity\":true,\"medical_accuracy_score\":\"5\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer (C) is the correct best answer. The stem provides classic features of PCP intoxication: vertical nystagmus, severe agitation, hypertonia, hyperthermia after smoking, and rhabdomyolysis (CK 5,200). These findings distinguish PCP from serotonin syndrome (which would show hyperreflexia, clonus, and often a serotonergic drug exposure) and from malignant hyperthermia (anesthetic trigger). The answer C (high‑dose IV benzodiazepines, active cooling, avoid physical restraints) aligns with current emergency management of dissociative intoxication. Alternative options are clearly inferior: A (dantrolene) is for malignant hyperthermia; B (succinylcholine) is contraindicated with rhabdomyolysis; D (cyproheptadine) targets serotonin syndrome; E (haloperidol) risks dystonia and worsens thermoregulation. No internal contradictions exist, and the vignette supplies enough discriminatory detail to select a single best answer. The only minor omission is that fluid resuscitation for rhabdomyolysis is not listed, but this does not undermine the correctness of C as the immediate next step. No medical inaccuracies are present. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-006", "question": "A 62-year-old woman with COPD (FEV1 35% predicted) presents with acute dyspnea and pleuritic chest pain. She is tachypneic and using accessory muscles. Vitals: T 37.3°C, HR 118, BP 92/60, RR 30, SpO₂ 86% on 4 L nasal cannula. Chest CT angiogram shows a large saddle pulmonary embolism with RV dilation. Troponin is mildly elevated, and bedside echo confirms RV dysfunction. She remains hypotensive despite a 500 mL fluid bolus and is started on norepinephrine. She received one prophylactic dose of LMWH 24 hours ago during a recent admission but no therapeutic anticoagulation. There is no history of recent surgery or intracranial hemorrhage. Which is the most appropriate immediate intervention?", "options": ["Systemic thrombolysis with IV alteplase", "Catheter-directed thrombolysis with local tPA infusion", "Emergent surgical pulmonary embolectomy", "IV unfractionated heparin alone with close hemodynamic monitoring", "Half-dose systemic tPA because of recent LMWH exposure"], "answer": "A", "answer_index": 0, "explanation": "She has massive PE with sustained hypotension and RV failure; in the absence of major contraindications, current guidelines recommend immediate systemic thrombolysis. Catheter-directed or surgical approaches are reserved when systemic thrombolysis is contraindicated or has failed. Prophylactic LMWH 24 hours prior is not a contraindication and does not mandate dose reduction.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: The keyed answer A is the correct best answer. The stem clearly describes a massive pulmonary embolism (PE) with sustained hypotension (BP 92/60, norepinephrine requirement), RV dilation on CT and RV dysfunction on echo, and hypoxemia—meeting criteria for massive PE. There are no contraindications to thrombolysis; prophylactic LMWH 24 h prior is not a contraindication and does not require dose reduction. Current ACCP/AHA/ESC guidelines recommend systemic thrombolysis as first-line therapy for massive PE without contraindications. Alternative options are appropriately placed as less suitable: catheter-directed thrombolysis (B) and surgical embolectomy (C) are reserved for contraindication/failure of systemic therapy; heparin alone (D) is insufficient for massive PE; half-dose tPA (E) is not indicated. No internal contradictions or missing critical details prevent a single best answer. Medical accuracy is high and aligns with contemporary evidence and standard board expectations. The scenario is realistic and fits board-style presentation. Minimal fix: none required.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: The keyed answer A is the correct best answer. The stem clearly describes a massive pulmonary embolism (PE) with sustained hypotension (BP 92/60, norepinephrine requirement), RV dilation on CT and RV dysfunction on echo, and hypoxemia—meeting criteria for massive PE. There are no contraindications to thrombolysis; prophylactic LMWH 24 h prior is not a contraindication and does not require dose reduction. Current ACCP/AHA/ESC guidelines recommend systemic thrombolysis as first-line therapy for massive PE without contraindications. Alternative options are appropriately placed as less suitable: catheter-directed thrombolysis (B) and surgical embolectomy (C) are reserved for contraindication/failure of systemic therapy; heparin alone (D) is insufficient for massive PE; half-dose tPA (E) is not indicated. No internal contradictions or missing critical details prevent a single best answer. Medical accuracy is high and aligns with contemporary evidence and standard board expectations. The scenario is realistic and fits board-style presentation. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-007", "question": "A 28-year-old man is brought to the ED after a high-speed MVC with hypotension and abdominal distension. FAST is positive in Morrison's pouch and pelvis. He undergoes emergent laparotomy with splenectomy and packing of diffuse hepatic oozing. Postoperatively in the ICU, he remains hypotensive despite 6 units PRBC, 6 units FFP, and 1 apheresis platelet unit. Core temperature is 33.5°C, pH 7.09, ionized calcium 0.9 mmol/L, and INR 2.4. Oozing continues from surgical drains. Which of the following is the next best step in management of his ongoing bleeding?", "options": ["Administer recombinant factor VIIa to promote thrombin generation", "Provide additional FFP and platelets guided by clinical judgment", "Initiate aggressive rewarming, calcium replacement, and correction of acidosis before further factor therapy", "Begin a continuous IV heparin infusion to treat consumptive coagulopathy", "Administer desmopressin to improve platelet adhesion"], "answer": "C", "answer_index": 2, "explanation": "This patient has the lethal triad of hypothermia, acidosis, and coagulopathy in massive trauma; correcting temperature, acidosis, and ionized calcium is crucial for coagulation to work and should precede or accompany further factor replacement. Recombinant factor VIIa is less effective and risky in this physiologic state, and empiric heparin or DDAVP will not address the fundamental problem.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\": The stem describes a trauma patient with massive hemorrhage, ongoing oozing, and the lethal triad of hypothermia (33.5°C), acidosis (pH 7.09), and coagulopathy (INR 2.4, low ionized calcium). The question asks for the next best step in managing ongoing bleeding. The lethal triad directly impairs coagulation enzyme activity and platelet function; correcting these derangements is the priority before additional factor or platelet therapy can be effective. The keyed answer (C) aligns with current trauma and massive transfusion protocols that emphasize rewarming, calcium repletion, and acidosis correction as the immediate life-saving maneuver. Option A (rFVIIa) is not first-line and is less effective in severe acidosis/hypothermia. Option B (more FFP/platelets) fails to address the metabolic milieu that prevents those products from working. Option D (heparin) is contraindicated in active bleeding. Option E (desmopressin) is not indicated for this diffuse coagulopathic bleeding. The stem provides sufficient discriminators (temperature, pH, calcium) to identify a unique best answer, and the key matches that answer. No internal contradictions or missing details prevent a single best choice. The medical content is accurate and consistent with ATLS and contemporary trauma coagulopathy management.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": ": The stem describes a trauma patient with massive hemorrhage, ongoing oozing, and the lethal triad of hypothermia (33.5°C), acidosis (pH 7.09), and coagulopathy (INR 2.4, low ionized calcium). The question asks for the next best step in managing ongoing bleeding. The lethal triad directly impairs coagulation enzyme activity and platelet function; correcting these derangements is the priority before additional factor or platelet therapy can be effective. The keyed answer (C) aligns with current trauma and massive transfusion protocols that emphasize rewarming, calcium repletion, and acidosis correction as the immediate life-saving maneuver. Option A (rFVIIa) is not first-line and is less effective in severe acidosis/hypothermia. Option B (more FFP/platelets) fails to address the metabolic milieu that prevents those products from working. Option D (heparin) is contraindicated in active bleeding. Option E (desmopressin) is not indicated for this diffuse coagulopathic bleeding. The stem provides sufficient discriminators (temperature, pH, calcium) to identify a unique best answer, and the key matches that answer. No internal contradictions or missing details prevent a single best choice. The medical content is accurate and consistent with ATLS and contemporary trauma coagulopathy management.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-008", "question": "A 54-year-old man with severe aortic stenosis and HFpEF is scheduled for open abdominal aortic aneurysm repair. Pre-op transthoracic echo shows AVA 0.7 cm², mean gradient 52 mmHg, LVEF 65%, and concentric LVH. He is asymptomatic at rest but develops dyspnea and presyncope with minimal exertion. Which intraoperative hemodynamic management strategy is most appropriate for this patient under general anesthesia?", "options": ["Maintain a relatively high-normal systemic vascular resistance and sinus rhythm with slow-normal heart rate", "Use vasodilatory anesthetic agents and permissive hypotension to reduce LV afterload", "Allow mild tachycardia to augment cardiac output and reduce LV filling pressures", "Aggressively diurese intraoperatively to avoid increases in LV end-diastolic volume", "Target low preload and low SVR with inodilators to optimize forward flow"], "answer": "A", "answer_index": 0, "explanation": "Severe fixed outflow obstruction requires maintenance of adequate preload, sinus rhythm, and relatively high SVR with a slow-normal heart rate to preserve coronary perfusion and cardiac output. Vasodilation, low SVR, low preload, and tachycardia can precipitate profound hypotension and ischemia in severe aortic stenosis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (valid). Verdict: Keyed answer A is the correct best choice. The stem’s key discriminating features—severe aortic stenosis (AVA 0.7 cm², mean gradient 52 mm Hg) with preserved EF and concentric LVH, symptomatic on minimal exertion—establish a fixed outflow obstruction in which coronary perfusion depends on diastolic pressure and sinus rhythm. The ideal intraoperative strategy is to maintain adequate preload, a high‑normal SVR, sinus rhythm, and a slow‑normal heart rate; this matches option A. Options B, C, D, and E each propose harmful maneuvers (vasodilation, tachycardia, aggressive diuresis, low preload/SVR) that would reduce coronary perfusion and precipitate hypotension/ischemia in severe AS. No internal contradictions or missing critical details; the presence of HFpEF does not alter the core hemodynamic goals for severe AS. The item therefore supports a single best answer, and the key aligns with it. Medical accuracy is consistent with current anesthesia and cardiology guidelines. No logical or medical flaws require revision.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (valid). Verdict: Keyed answer A is the correct best choice. The stem’s key discriminating features—severe aortic stenosis (AVA 0.7 cm², mean gradient 52 mm Hg) with preserved EF and concentric LVH, symptomatic on minimal exertion—establish a fixed outflow obstruction in which coronary perfusion depends on diastolic pressure and sinus rhythm. The ideal intraoperative strategy is to maintain adequate preload, a high‑normal SVR, sinus rhythm, and a slow‑normal heart rate; this matches option A. Options B, C, D, and E each propose harmful maneuvers (vasodilation, tachycardia, aggressive diuresis, low preload/SVR) that would reduce coronary perfusion and precipitate hypotension/ischemia in severe AS. No internal contradictions or missing critical details; the presence of HFpEF does not alter the core hemodynamic goals for severe AS. The item therefore supports a single best answer, and the key aligns with it. Medical accuracy is consistent with current anesthesia and cardiology guidelines. No logical or medical flaws require revision.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-009", "question": "A 40-year-old woman with morbid obesity (BMI 48 kg/m²) and obstructive sleep apnea is undergoing laparoscopic cholecystectomy under general anesthesia. After intubation with a standard endotracheal tube, her peak inspiratory pressures rapidly rise to 40 cm H₂O, with SpO₂ 89% despite FiO₂ 1.0. Auscultation reveals absent breath sounds over the left lung and harsh sounds over the right. Capnography shows a normal waveform. Blood pressure and heart rate are stable. Which of the following is the most appropriate immediate step?", "options": ["Administer a bronchodilator for presumed severe bronchospasm", "Withdraw the endotracheal tube slightly while listening for bilateral breath sounds", "Place a left chest tube for suspected tension pneumothorax", "Increase PEEP and tidal volume to recruit atelectatic lung units", "Obtain stat portable chest radiograph to confirm tube positioning"], "answer": "B", "answer_index": 1, "explanation": "Unilateral (right-sided) breath sounds and high peak pressures immediately after intubation strongly suggest endobronchial intubation; the correct immediate response is to withdraw the tube under auscultation until bilateral breath sounds are heard. Bronchospasm would typically cause diffuse wheezing; tension pneumothorax would more likely cause hemodynamic compromise; imaging should not delay simple corrective maneuvers.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. The stem describes immediate post-intubation hypoxemia with unilateral absent breath sounds (left), harsh right-sided sounds, markedly elevated peak inspiratory pressures, normal capnography waveform, and stable hemodynamics—pathognomonic for right mainstem endobronchial intubation. Key discriminating clues include the temporal proximity to intubation, asymmetric auscultation, and hemodynamic stability arguing against tension pneumothorax. The keyed answer B (withdraw endotracheal tube slightly while auscultating) represents the standard immediate corrective action, defensible without radiographic confirmation. Alternative options are appropriately excluded: A (bronchodilator) would not address unilateral findings; C (left chest tube) is contraindicated by stable vitals and lacks tracheal deviation; D (increase PEEP/tidal volume) risks barotrauma to a single ventilated lung; E (stat CXR) unacceptably delays definitive management. No logical flaws exist: a single best answer is clearly identifiable, the key matches, and options permit clean discrimination. Medical accuracy is gold-standard, consistent with ASA difficult airway guidelines and anesthesia practice standards. No contradictions, underspecification, or outdated content. Minimal fix: none required; item is board-examination ready.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. The stem describes immediate post-intubation hypoxemia with unilateral absent breath sounds (left), harsh right-sided sounds, markedly elevated peak inspiratory pressures, normal capnography waveform, and stable hemodynamics—pathognomonic for right mainstem endobronchial intubation. Key discriminating clues include the temporal proximity to intubation, asymmetric auscultation, and hemodynamic stability arguing against tension pneumothorax. The keyed answer B (withdraw endotracheal tube slightly while auscultating) represents the standard immediate corrective action, defensible without radiographic confirmation. Alternative options are appropriately excluded: A (bronchodilator) would not address unilateral findings; C (left chest tube) is contraindicated by stable vitals and lacks tracheal deviation; D (increase PEEP/tidal volume) risks barotrauma to a single ventilated lung; E (stat CXR) unacceptably delays definitive management. No logical flaws exist: a single best answer is clearly identifiable, the key matches, and options permit clean discrimination. Medical accuracy is gold-standard, consistent with ASA difficult airway guidelines and anesthesia practice standards. No contradictions, underspecification, or outdated content. Minimal fix: none required; item is board-examination ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-010", "question": "A 23-year-old man with treatment-resistant schizophrenia is receiving clozapine 350 mg/day. Baseline ANC was 3,200/µL. At week 10, he presents with 3 days of fever, malaise, and sore throat. Exam shows mild pharyngeal erythema without exudates. Labs: WBC 1,200/µL, ANC 380/µL, hemoglobin 13.4 g/dL, platelets 220,000/µL. Rapid strep test is negative. Which of the following is the most appropriate management of his psychotropic regimen?", "options": ["Continue clozapine at the same dose while starting broad-spectrum antibiotics", "Reduce clozapine to 50% of the current dose and monitor CBC weekly", "Stop clozapine immediately and permanently discontinue it", "Switch from clozapine to another second-generation antipsychotic after ANC recovery", "Administer G-CSF and continue clozapine to avoid psychotic relapse"], "answer": "C", "answer_index": 2, "explanation": "An ANC <500/µL on clozapine represents agranulocytosis and requires immediate and permanent discontinuation per monitoring guidelines. G-CSF may be considered but clozapine should not be continued. Dose reduction or switching later without permanent discontinuation risks recurrence of life-threatening neutropenia.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. The stem provides a classic scenario of clozapine-induced agranulocytosis: a patient on clozapine with baseline normal ANC (3,200/µL) develops fever, sore throat, and ANC <500/µL (380/µL) at week 10. These findings meet the FDA REMS definition of severe neutropenia requiring immediate and permanent discontinuation of clozapine. The keyed answer C aligns with current guidelines: stop clozapine immediately and do not rechallenge. Options A, B, D, and E are all inferior: continuing clozapine (A, E) or dose reduction (B) is contraindicated; switching after recovery (D) describes a later step but not the immediate psychotropic management. No internal contradictions or missing details prevent a single best answer. Medical accuracy is high: the ANC threshold, clinical presentation, and mandated permanent discontinuation are correctly represented. A minor clarification could be added to the stem to specify \\\"immediate\\\" management, but the item is already unambiguous. No factual errors or outdated guidance are present. Score: 5.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The stem provides a classic scenario of clozapine-induced agranulocytosis: a patient on clozapine with baseline normal ANC (3,200/µL) develops fever, sore throat, and ANC <500/µL (380/µL) at week 10. These findings meet the FDA REMS definition of severe neutropenia requiring immediate and permanent discontinuation of clozapine. The keyed answer C aligns with current guidelines: stop clozapine immediately and do not rechallenge. Options A, B, D, and E are all inferior: continuing clozapine (A, E) or dose reduction (B) is contraindicated; switching after recovery (D) describes a later step but not the immediate psychotropic management. No internal contradictions or missing details prevent a single best answer. Medical accuracy is high: the ANC threshold, clinical presentation, and mandated permanent discontinuation are correctly represented. A minor clarification could be added to the stem to specify \"immediate\" management, but the item is already unambiguous. No factual errors or outdated guidance are present. Score: 5.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-011", "question": "A 9-year-old boy presents with recurrent episodes of facial flushing, headache, tachycardia, and severe hypertension. Episodes last 20-30 minutes and resolve spontaneously. Between episodes, his blood pressure is mildly elevated. Exam shows café-au-lait macules and multiple cutaneous neurofibromas. Plasma free metanephrines are markedly elevated. MRI abdomen shows a 2.5-cm left adrenal mass and a 1.2-cm right adrenal mass. Genetic testing is pending. Which of the following is the most appropriate next step in management?", "options": ["Unilateral laparoscopic left adrenalectomy to minimize risk of adrenal insufficiency", "Bilateral laparoscopic adrenalectomy with lifelong glucocorticoid and mineralocorticoid replacement", "Begin nonselective beta-blocker therapy, then alpha-blockade after HR control", "Initiate alpha-adrenergic blockade followed by beta-blockade and plan for cortical-sparing adrenal surgery", "Observe with annual imaging because most pediatric pheochromocytomas regress spontaneously"], "answer": "D", "answer_index": 3, "explanation": "This child with NF1 and bilateral adrenal lesions likely has hereditary pheochromocytomas; preoperative management requires alpha-blockade first, then beta-blockade, followed by surgery. In hereditary/bilateral disease, cortical-sparing adrenalectomy is preferred to reduce long-term adrenal insufficiency risk. Beta-blockade before alpha-blockade can precipitate a hypertensive crisis.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Keyed answer D is the unique best choice. Stem clues—episodic flushing, headache, tachycardia, severe hypertension; markedly elevated plasma free metanephrines; bilateral adrenal masses; café-au-lait macules and neurofibromas—establish hereditary pheochromocytoma in NF1. Standard management mandates alpha-blockade first, then beta-blockade, followed by surgery; in bilateral disease, cortical-sparing adrenalectomy avoids lifelong adrenal insufficiency. Option D correctly incorporates blockade sequence and surgical plan. Alternatives are definitively wrong: A and B omit blockade and propose inappropriate unilateral or bilateral total adrenalectomy; C reverses blockade order, risking hypertensive crisis; E falsely claims spontaneous regression. No internal contradictions or missing critical details; a single best answer is unambiguous. Medical accuracy is gold-standard, aligning with Endocrine Society guidelines and pediatric endocrine surgical consensus. Distractors are plausible but clearly inferior. Minimal fix: none; item is board-ready.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Keyed answer D is the unique best choice. Stem clues—episodic flushing, headache, tachycardia, severe hypertension; markedly elevated plasma free metanephrines; bilateral adrenal masses; café-au-lait macules and neurofibromas—establish hereditary pheochromocytoma in NF1. Standard management mandates alpha-blockade first, then beta-blockade, followed by surgery; in bilateral disease, cortical-sparing adrenalectomy avoids lifelong adrenal insufficiency. Option D correctly incorporates blockade sequence and surgical plan. Alternatives are definitively wrong: A and B omit blockade and propose inappropriate unilateral or bilateral total adrenalectomy; C reverses blockade order, risking hypertensive crisis; E falsely claims spontaneous regression. No internal contradictions or missing critical details; a single best answer is unambiguous. Medical accuracy is gold-standard, aligning with Endocrine Society guidelines and pediatric endocrine surgical consensus. Distractors are plausible but clearly inferior. Minimal fix: none; item is board-ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-012", "question": "A 2-year-old girl has recurrent episodes of early-morning lethargy, diaphoresis, and seizures. During an event, serum glucose is 28 mg/dL, insulin is inappropriately elevated, C-peptide is high, and beta-hydroxybutyrate is suppressed. Critical labs show elevated ammonia and mildly elevated lactate. Diazoxide therapy fails to control episodes, and octreotide provides partial benefit. Genetic testing reveals a heterozygous activating mutation in GLUD1. Which of the following dietary recommendations is most appropriate?", "options": ["Strict protein restriction with particular emphasis on limiting leucine intake", "High-protein, low-carbohydrate diet to reduce insulin secretion", "Avoidance of protein loads, especially leucine-rich meals, due to mutation-specific sensitivity", "Frequent high-carbohydrate snacks to prevent fasting hypoglycemia while encouraging free protein intake", "Ketogenic diet to provide alternative fuel and decrease insulin secretion"], "answer": "C", "answer_index": 2, "explanation": "GLUD1-activating mutations cause hyperinsulinism-hyperammonemia; protein- (particularly leucine-) induced hyperinsulinism is typical, so avoiding protein loads and limiting leucine is recommended along with medical therapy. Pure protein restriction without attention to leucine misses the key trigger, and high-protein or ketogenic diets may exacerbate protein-induced insulin secretion.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: early‑morning hypoglycemia (28 mg/dL), inappropriately elevated insulin and C‑peptide, suppressed β‑hydroxybutyrate, hyperammonemia, mild lactate elevation, heterozygous activating GLUD1 mutation, resistance to diazoxide and partial response to octreotide. These findings define the hyperinsulinism‑hyperammonemia (HI/HA) syndrome caused by GLUD1 gain‑of‑function, which is characteristically triggered by protein (especially leucine) ingestion. Option C directly addresses this by recommending avoidance of protein loads, particularly leucine‑rich meals, and cites the mutation‑specific sensitivity. Options A and C are similar, but A’s wording (“strict protein restriction with particular emphasis on limiting leucine”) could be interpreted as broader restriction, whereas C is more precise and aligns with current dietary management of GLUD1‑HI. Options B, D, and E would worsen protein‑driven insulin secretion or are contraindicated. No internal contradictions; a single best answer is clearly defensible. Medical accuracy: fully consistent with published guidelines (e.g., ADA/ESPE) and recent literature on GLUD1‑HI. Minimal fix: rephrase option A to \\\"Strict protein restriction without specific leucine limitation\\\" to eliminate overlap and sharpen distinction from option C.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: Correct best answer. Key stem clues: early‑morning hypoglycemia (28 mg/dL), inappropriately elevated insulin and C‑peptide, suppressed β‑hydroxybutyrate, hyperammonemia, mild lactate elevation, heterozygous activating GLUD1 mutation, resistance to diazoxide and partial response to octreotide. These findings define the hyperinsulinism‑hyperammonemia (HI/HA) syndrome caused by GLUD1 gain‑of‑function, which is characteristically triggered by protein (especially leucine) ingestion. Option C directly addresses this by recommending avoidance of protein loads, particularly leucine‑rich meals, and cites the mutation‑specific sensitivity. Options A and C are similar, but A’s wording (“strict protein restriction with particular emphasis on limiting leucine”) could be interpreted as broader restriction, whereas C is more precise and aligns with current dietary management of GLUD1‑HI. Options B, D, and E would worsen protein‑driven insulin secretion or are contraindicated. No internal contradictions; a single best answer is clearly defensible. Medical accuracy: fully consistent with published guidelines (e.g., ADA/ESPE) and recent literature on GLUD1‑HI. Minimal fix: rephrase option A to \"Strict protein restriction without specific leucine limitation\" to eliminate overlap and sharpen distinction from option C.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-013", "question": "A 5-year-old boy presents with progressive ataxia and frequent falls over 1 year. Parents report slurred speech and difficulty swallowing liquids. Exam shows truncal ataxia, bilateral gaze-evoked nystagmus, dysarthria, and limb dysmetria. There is mild facial weakness and hyperreflexia in all extremities with bilateral extensor plantar responses. MRI brain shows cerebellar atrophy and T2 hyperintensity in the dorsal medulla and upper cervical spinal cord. Serum vitamin E, copper, and B12 levels are normal. Genetic panel identifies biallelic mutations in SLC52A2. Which of the following is the most appropriate disease-modifying treatment?", "options": ["High-dose oral vitamin E supplementation", "High-dose oral riboflavin therapy", "Parenteral copper replacement", "Oral coenzyme Q10 and idebenone", "IV immunoglobulin and high-dose steroids"], "answer": "B", "answer_index": 1, "explanation": "SLC52A2 mutations cause riboflavin transporter deficiency (riboflavin transporter deficiency type 2), a treatable neurometabolic disorder; high-dose oral riboflavin can stabilize or improve neurologic function. Vitamin E and copper deficiency have similar phenotypes but normal levels and genetic confirmation rule them out. CoQ10 and immunotherapy are not disease-modifying here.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). Verdict: The keyed answer B is the correct best answer. The stem’s pivotal clue is the identification of biallelic SLC52A2 mutations, which cause riboflavin transporter deficiency type 2 (RTD2), a treatable neurometabolic disorder. In a child with progressive cerebellar ataxia, dysarthria, dysphagia, cerebellar atrophy, and dorsal medulla/cervical cord T2 hyperintensity, the genetic result uniquely establishes RTD2. High-dose oral riboflavin is the established disease-modifying therapy, often stabilizing or improving neurologic function by replenishing flavin cofactors essential for oxidative phosphorylation and neuronal survival. Without supplementation, patients undergo progressive neurodegeneration; early treatment can reverse deficits and prevent further damage. Alternative options are indefensible: vitamin E and copper supplementation are excluded by normal serum levels; CoQ10/idebenone lack evidence in RTD2; IVIG/steroids are inappropriate for this genetic metabolic disease. No internal contradictions or missing details prevent a single best answer. The item aligns with current neurometabolic guidelines and is board-relevant. No fix required.\",\n\"medical_accuracy_score\":  \t \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: The keyed answer B is the correct best answer. The stem’s pivotal clue is the identification of biallelic SLC52A2 mutations, which cause riboflavin transporter deficiency type 2 (RTD2), a treatable neurometabolic disorder. In a child with progressive cerebellar ataxia, dysarthria, dysphagia, cerebellar atrophy, and dorsal medulla/cervical cord T2 hyperintensity, the genetic result uniquely establishes RTD2. High-dose oral riboflavin is the established disease-modifying therapy, often stabilizing or improving neurologic function by replenishing flavin cofactors essential for oxidative phosphorylation and neuronal survival. Without supplementation, patients undergo progressive neurodegeneration; early treatment can reverse deficits and prevent further damage. Alternative options are indefensible: vitamin E and copper supplementation are excluded by normal serum levels; CoQ10/idebenone lack evidence in RTD2; IVIG/steroids are inappropriate for this genetic metabolic disease. No internal contradictions or missing details prevent a single best answer. The item aligns with current neurometabolic guidelines and is board-relevant. No fix required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-014", "question": "A 16-year-old girl presents with acute right lower quadrant pain and vomiting. She is sexually inactive. Vitals: T 37.4°C, HR 104, BP 112/70. Abdomen: guarding and rebound in the RLQ. WBC 11,000/µL. Pelvic ultrasound shows a 7-cm right ovarian cyst with echogenic debris and a single peripheral solid nodule (mural nodule) with internal blood flow; Doppler shows preserved arterial and venous flow to the ovary. The appendix is not clearly visualized. Which of the following is the most appropriate next step?", "options": ["Discharge with NSAIDs and repeat ultrasound in 6 weeks for presumed functional cyst", "Start broad-spectrum IV antibiotics and observe for signs of tubo-ovarian abscess", "Urgent diagnostic laparoscopy with ovarian-sparing cystectomy", "CT abdomen with IV contrast to better visualize the appendix before any surgery", "Tumor marker panel and elective surgery in 3 months if the cyst persists"], "answer": "C", "answer_index": 2, "explanation": "A large (7 cm) complex ovarian cyst with a vascular mural nodule in an adolescent with acute pain warrants urgent laparoscopy with ovarian-sparing cystectomy to treat possible torsion or neoplasm while preserving ovarian tissue. Delaying surgery risks torsion and malignancy progression; normal flow does not exclude intermittent torsion.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V. Verdict: Correct best answer. Key discriminating clues: adolescent female, acute RLQ pain with vomiting/guarding, 7-cm complex ovarian cyst with echogenic debris and vascular mural nodule, preserved but nondiagnostic Doppler flow, sexual inactivity, and nonvisualized appendix. This constellation mandates urgent surgical evaluation for torsion or neoplasm. The keyed answer C (urgent diagnostic laparoscopy with ovarian-sparing cystectomy) is superior because it provides simultaneous diagnosis and treatment while preserving ovarian tissue. Alternatives are clearly inferior: A dangerously observes a high-risk cyst; B misdirects toward an unlikely TOA; D delays care with unnecessary radiation; E postpones urgent evaluation. No internal contradictions exist; laparoscopy permits assessment of both ovarian and appendiceal pathology. Medical accuracy is gold-standard: the approach aligns with ACOG/ASRM recommendations for large complex adnexal masses in adolescents, and the rationale correctly emphasizes that normal Doppler does not exclude intermittent torsion. Minimal fix: none required.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key discriminating clues: adolescent female, acute RLQ pain with vomiting/guarding, 7-cm complex ovarian cyst with echogenic debris and vascular mural nodule, preserved but nondiagnostic Doppler flow, sexual inactivity, and nonvisualized appendix. This constellation mandates urgent surgical evaluation for torsion or neoplasm. The keyed answer C (urgent diagnostic laparoscopy with ovarian-sparing cystectomy) is superior because it provides simultaneous diagnosis and treatment while preserving ovarian tissue. Alternatives are clearly inferior: A dangerously observes a high-risk cyst; B misdirects toward an unlikely TOA; D delays care with unnecessary radiation; E postpones urgent evaluation. No internal contradictions exist; laparoscopy permits assessment of both ovarian and appendiceal pathology. Medical accuracy is gold-standard: the approach aligns with ACOG/ASRM recommendations for large complex adnexal masses in adolescents, and the rationale correctly emphasizes that normal Doppler does not exclude intermittent torsion. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-015", "question": "A 47-year-old man with a history of alcohol use disorder presents with sudden severe epigastric pain radiating to the back and persistent vomiting. He appears toxic. Vitals: T 38.8°C, HR 130, BP 84/52, RR 28, SpO₂ 92% RA. Exam: diffuse abdominal tenderness with guarding. Labs: WBC 22,000/µL, Hct 44%, Cr 2.1 mg/dL, lipase 2,500 U/L, lactate 4.2 mmol/L. CT abdomen with contrast shows edematous pancreas with multiple non-enhancing areas >30% of gland and gas bubbles within collections; there is peripancreatic fat stranding and fluid. Which of the following is the most appropriate immediate management strategy?", "options": ["Emergent surgical pancreatic necrosectomy", "Percutaneous catheter drainage of infected collections plus broad-spectrum IV antibiotics", "Conservative management with IV fluids and analgesia only, as necrosectomy is delayed until 4 weeks", "Endoscopic transluminal necrosectomy within the next 12 hours", "Immediate ERCP with sphincterotomy and pancreatic duct stent placement"], "answer": "B", "answer_index": 1, "explanation": "He has infected necrotizing pancreatitis (gas in necrosis, sepsis). Current evidence favors a step-up approach: initial percutaneous drainage with antibiotics, reserving delayed minimally invasive or surgical necrosectomy for failure of drainage. Emergent open necrosectomy is associated with high mortality; ERCP is indicated mainly for cholangitis/obstructive stones, not for necrotizing disease alone.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: The keyed answer B is the correct best answer. Key stem clues: CT shows gas bubbles within non-enhancing pancreatic parenchyma involving >30% of the gland, a hallmark of infected necrosis; the patient is hypotensive (BP 84/52), tachycardic (HR 130), febrile (T 38.8 °C) with marked leukocytosis (WBC 22 000/µL) and elevated lactate (4.2 mmol/L), confirming septic shock. These findings require urgent source control. Main logical issue(s): None; the vignette supplies all necessary discriminators (infected necrosis, hemodynamic instability) to select a single best immediate management step without ambiguity. Main medical accuracy issue(s): None; current IAP/APA and ACG guidelines endorse a step‑up strategy beginning with percutaneous (or endoscopic) drainage and broad‑spectrum antibiotics for infected necrotizing pancreatitis, reserving surgical necrosectomy for later or for failure of drainage. Options A, C, D, and E are appropriately less suitable: emergent open necrosectomy (A) carries excessive mortality; conservative therapy alone (C) fails to address infection; early endoscopic necrosectomy (D) is not the first step; and ERCP (E) is reserved for cholangitis or biliary obstruction, which are not present. Minimal fix: No change required.\",\n\"medical_accuracy_score\":  \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer B is the correct best answer. Key stem clues: CT shows gas bubbles within non-enhancing pancreatic parenchyma involving >30% of the gland, a hallmark of infected necrosis; the patient is hypotensive (BP 84/52), tachycardic (HR 130), febrile (T 38.8 °C) with marked leukocytosis (WBC 22 000/µL) and elevated lactate (4.2 mmol/L), confirming septic shock. These findings require urgent source control. Main logical issue(s): None; the vignette supplies all necessary discriminators (infected necrosis, hemodynamic instability) to select a single best immediate management step without ambiguity. Main medical accuracy issue(s): None; current IAP/APA and ACG guidelines endorse a step‑up strategy beginning with percutaneous (or endoscopic) drainage and broad‑spectrum antibiotics for infected necrotizing pancreatitis, reserving surgical necrosectomy for later or for failure of drainage. Options A, C, D, and E are appropriately less suitable: emergent open necrosectomy (A) carries excessive mortality; conservative therapy alone (C) fails to address infection; early endoscopic necrosectomy (D) is not the first step; and ERCP (E) is reserved for cholangitis or biliary obstruction, which are not present. Minimal fix: No change required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-016", "question": "A 63-year-old woman on chronic warfarin for mechanical mitral valve presents after a fall with headache and confusion. CT head reveals a 1.8-cm left frontal intraparenchymal hemorrhage with minimal mass effect. INR is 4.5. Vitals: BP 162/94, HR 92, RR 18, SpO₂ 96% RA. She is drowsy but arousable, with no focal deficits. Which of the following is the most appropriate strategy for reversing anticoagulation?", "options": ["IV vitamin K alone at 10 mg over 30 minutes", "Four-factor PCC plus IV vitamin K 10 mg", "Fresh frozen plasma alone at 15 mL/kg", "Protamine sulfate followed by IV vitamin K 5 mg", "Activated prothrombin complex concentrate (FEIBA) without vitamin K"], "answer": "B", "answer_index": 1, "explanation": "In warfarin-associated intracerebral hemorrhage, guidelines recommend rapid reversal with four-factor PCC plus IV vitamin K to sustain reversal. FFP alone is slower and requires large volumes; vitamin K alone acts too slowly; protamine reverses heparin, not warfarin; aPCC without vitamin K may reverse acutely but not maintain correction.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. Key stem clues driving a unique best answer: (1) chronic warfarin for high-risk mechanical mitral valve, (2) confirmed left frontal intraparenchymal hemorrhage, (3) INR 4.5 (supratherapeutic), and (4) clinical presentation (drowsy, minimal mass effect) where rapid reversal is critical to prevent hematoma expansion. These elements mandate immediate, sustained warfarin reversal per AHA/ASA ICH guidelines. Option B (four-factor PCC + IV vitamin K) is uniquely defensible as it provides rapid INR correction and sustained maintenance. Main logical issue(s): None; options are mutually exclusive and permit clear discrimination—A acts too slowly for acute ICH, C is slower and volume-limited, D targets heparin (wrong drug class), and E lacks vitamin K for durable reversal. Main medical accuracy issue(s): None; the item accurately reflects current standard of care and board-relevant management. The explanation correctly distinguishes mechanism, speed, and durability of reversal strategies. Minimal fix: No edit required; item is well-constructed and ready for high-stakes examination use.\",\"medical_accuracy_score\":   \"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. Key stem clues driving a unique best answer: (1) chronic warfarin for high-risk mechanical mitral valve, (2) confirmed left frontal intraparenchymal hemorrhage, (3) INR 4.5 (supratherapeutic), and (4) clinical presentation (drowsy, minimal mass effect) where rapid reversal is critical to prevent hematoma expansion. These elements mandate immediate, sustained warfarin reversal per AHA/ASA ICH guidelines. Option B (four-factor PCC + IV vitamin K) is uniquely defensible as it provides rapid INR correction and sustained maintenance. Main logical issue(s): None; options are mutually exclusive and permit clear discrimination—A acts too slowly for acute ICH, C is slower and volume-limited, D targets heparin (wrong drug class), and E lacks vitamin K for durable reversal. Main medical accuracy issue(s): None; the item accurately reflects current standard of care and board-relevant management. The explanation correctly distinguishes mechanism, speed, and durability of reversal strategies. Minimal fix: No edit required; item is well-constructed and ready for high-stakes examination use.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-017", "question": "A 29-year-old man presents to the ED agitated and disoriented after ingesting an unknown quantity of sustained-release verapamil in a suicide attempt 3 hours ago. Vitals: T 36.6°C, HR 42, BP 78/40, RR 22, SpO₂ 97% RA. He has cool extremities and delayed capillary refill. ECG: sinus bradycardia with PR prolongation. Initial management includes IV fluids and 1 g of IV calcium chloride with transient minimal BP improvement. Which of the following is the most appropriate next therapy?", "options": ["High-dose insulin euglycemia therapy with concomitant dextrose and potassium monitoring", "IV glucagon bolus followed by continuous infusion", "Continuous naloxone infusion for possible co-ingested opioids", "Immediate transvenous pacing to correct bradycardia", "Emergent hemodialysis to enhance verapamil clearance"], "answer": "A", "answer_index": 0, "explanation": "For severe calcium channel blocker toxicity, high-dose insulin euglycemia therapy improves inotropy and peripheral utilization of glucose and is now a mainstay after calcium and fluids. Glucagon is more effective for beta-blocker overdose; transvenous pacing does not correct vasodilation or inotropy; verapamil is highly protein-bound and not dialyzable.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity: V (Valid). Verdict: Keyed answer is correct best answer. Key stem clues: sustained-release verapamil ingestion 3 hours ago, severe hypotension (78/40) with bradycardia (HR 42) and PR prolongation, poor peripheral perfusion (cool extremities, delayed cap refill), and minimal transient response to calcium. These findings define severe calcium channel blocker toxicity with cardiogenic shock. The question asks for the most appropriate next therapy after fluids and calcium. High-dose insulin euglycemia (HIE) therapy is the established first-line antidote for severe CCB poisoning, improving inotropic support and myocardial glucose utilization. Alternative options are appropriately discriminated: glucagon (B) is primarily for beta-blocker toxicity; naloxone (C) lacks indication without opioid co-ingestion; transvenous pacing (D) addresses only bradycardia, not vasodilation or inotropy; hemodialysis (E) is ineffective due to verapamil's high protein binding and large volume of distribution. No logical flaws or medical inaccuracies. The item is board-style appropriate. Minimal fix: None required; item is well-constructed.\",\n\"medical_accuracy_score\":   \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Keyed answer is correct best answer. Key stem clues: sustained-release verapamil ingestion 3 hours ago, severe hypotension (78/40) with bradycardia (HR 42) and PR prolongation, poor peripheral perfusion (cool extremities, delayed cap refill), and minimal transient response to calcium. These findings define severe calcium channel blocker toxicity with cardiogenic shock. The question asks for the most appropriate next therapy after fluids and calcium. High-dose insulin euglycemia (HIE) therapy is the established first-line antidote for severe CCB poisoning, improving inotropic support and myocardial glucose utilization. Alternative options are appropriately discriminated: glucagon (B) is primarily for beta-blocker toxicity; naloxone (C) lacks indication without opioid co-ingestion; transvenous pacing (D) addresses only bradycardia, not vasodilation or inotropy; hemodialysis (E) is ineffective due to verapamil's high protein binding and large volume of distribution. No logical flaws or medical inaccuracies. The item is board-style appropriate. Minimal fix: None required; item is well-constructed.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-018", "question": "A 67-year-old man with severe COPD (baseline PaCO₂ 58 mmHg) and chronic hypercapnic respiratory failure undergoes open inguinal hernia repair under general anesthesia. In the PACU, he is somnolent with shallow breathing. Vitals: T 36.8°C, HR 96, BP 138/82, RR 8, SpO₂ 94% on 2 L nasal cannula. ABG: pH 7.18, PaCO₂ 85 mmHg, PaO₂ 80 mmHg, HCO₃⁻ 30 mEq/L. He received morphine PCA and midazolam intraoperatively. Pupils are 2 mm and reactive, with no focal deficits. Which is the most appropriate immediate management?", "options": ["Administer naloxone in incremental IV doses and monitor ventilatory response", "Start noninvasive positive-pressure ventilation (BiPAP) without altering analgesics", "Intubate and mechanically ventilate given pH <7.20 and PaCO₂ >80 mmHg", "Administer flumazenil and discontinue benzodiazepines", "Increase supplemental oxygen to maintain SpO₂ >98% and observe closely"], "answer": "A", "answer_index": 0, "explanation": "Acute hypercapnic respiratory depression in a postoperative COPD patient with opioid exposure and miosis suggests opioid-induced hypoventilation; naloxone titrated in small IV doses is appropriate first-line therapy. BiPAP may help but should follow reversal of opioid effect; immediate intubation is not mandatory if ventilation improves with naloxone. Flumazenil carries seizure risk and is less clearly indicated here.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict on keyed answer: Correct best answer. Key stem clues: severe COPD with chronic hypercapnia (baseline PaCO₂ 58 mmHg), recent intraoperative morphine PCA and midazolam, pinpoint pupils (2 mm), somnolence, shallow breathing, acute rise in PaCO₂ to 85 mmHg and pH 7.18. These findings strongly point to opioid‑induced respiratory depression as the primary driver of the acute hypercapnic acidosis. Naloxone, titrated in small IV increments, directly reverses the opioid effect and is the recommended first‑line therapy for postoperative opioid overdose. Alternative options are less appropriate: BiPAP without altering analgesics would not address the opioid effect and may be poorly tolerated in a somnolent patient; intubation is not mandatory if ventilation improves with reversal; flumazenil is not indicated (no benzodiazepine toxicity signs) and carries seizure risk; increasing O₂ may worsen CO₂ retention in a chronic CO₂ retainer. No internal contradictions or missing critical details prevent selection of a single best answer. Medical accuracy: The keyed answer aligns with current ASA/ACCM guidelines for opioid‑induced respiratory depression and post‑operative management. Minimal fix: None required; item is board‑ready.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict on keyed answer: Correct best answer. Key stem clues: severe COPD with chronic hypercapnia (baseline PaCO₂ 58 mmHg), recent intraoperative morphine PCA and midazolam, pinpoint pupils (2 mm), somnolence, shallow breathing, acute rise in PaCO₂ to 85 mmHg and pH 7.18. These findings strongly point to opioid‑induced respiratory depression as the primary driver of the acute hypercapnic acidosis. Naloxone, titrated in small IV increments, directly reverses the opioid effect and is the recommended first‑line therapy for postoperative opioid overdose. Alternative options are less appropriate: BiPAP without altering analgesics would not address the opioid effect and may be poorly tolerated in a somnolent patient; intubation is not mandatory if ventilation improves with reversal; flumazenil is not indicated (no benzodiazepine toxicity signs) and carries seizure risk; increasing O₂ may worsen CO₂ retention in a chronic CO₂ retainer. No internal contradictions or missing critical details prevent selection of a single best answer. Medical accuracy: The keyed answer aligns with current ASA/ACCM guidelines for opioid‑induced respiratory depression and post‑operative management. Minimal fix: None required; item is board‑ready.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-019", "question": "A 45-year-old woman with a history of Roux-en-Y gastric bypass presents for elective laparoscopic hysterectomy under general anesthesia. She reports easy bruising, heavy menses, and occasional gum bleeding. Pre-op labs: platelets 260,000/µL, PT 13 sec (INR 1.0), aPTT 34 sec, fibrinogen 390 mg/dL. vWF antigen is 45% (low), ristocetin cofactor activity 42% (low), and factor VIII activity 52%. Multimer analysis shows loss of high-molecular-weight multimers. Which perioperative hemostatic strategy is most appropriate?", "options": ["Desmopressin (DDAVP) alone immediately before surgery", "vWF-containing factor VIII concentrate infusion before and during surgery", "Cryoprecipitate transfusion to replace fibrinogen and vWF multimers", "Platelet transfusion immediately pre-op to increase vWF release", "Recombinant activated factor VII infusion at incision time"], "answer": "B", "answer_index": 1, "explanation": "Low vWF with loss of high-molecular-weight multimers suggests type 2A or 2B von Willebrand disease; DDAVP can be ineffective or risky (especially in type 2B). vWF-containing factor VIII concentrate provides the most predictable correction. Cryoprecipitate has variable vWF content; platelet transfusion is not first-line; rFVIIa is reserved for refractory bleeding.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\n\"analysis\": \"Validity label: V (Valid). Verdict: The keyed answer B is the correct best choice. Key stem clues are low vWF antigen (45 %) and ristocetin cofactor activity (42 %) with loss of high‑molecular‑weight multimers, normal platelet count, normal PT/INR and aPTT, and clinical bleeding (easy bruising, heavy menses, gum bleeding). This pattern defines type 2A (or 2B) von Willebrand disease, in which DDAVP is unreliable or may precipitate thrombocytopenia (type 2B). Current NHLBI/ISTH guidelines recommend a vWF‑containing factor VIII concentrate (e.g., Humate‑P) for perioperative hemostasis in type 2A/2B VWD because it provides predictable amounts of functional vWF and factor VIII. Option A (DDAVP alone) is inappropriate for type 2A/2B. Option C (cryoprecipitate) has variable vWF content, carries infectious risks, and is not first‑line. Option D (platelet transfusion) does not correct the plasma vWF deficiency and is not indicated. Option E (rFVIIa) is reserved for life‑threatening bleeding refractory to standard therapy. No internal contradictions exist, and the stem supplies all necessary data to select a single best answer. Main medical accuracy issue: none; the answer aligns with contemporary VWD management. Minimal fix: none required.\",\n\"medical_accuracy_score\":  \t \t\"5\",\n\"logical_validity\": true,\n\"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V (Valid). Verdict: The keyed answer B is the correct best choice. Key stem clues are low vWF antigen (45 %) and ristocetin cofactor activity (42 %) with loss of high‑molecular‑weight multimers, normal platelet count, normal PT/INR and aPTT, and clinical bleeding (easy bruising, heavy menses, gum bleeding). This pattern defines type 2A (or 2B) von Willebrand disease, in which DDAVP is unreliable or may precipitate thrombocytopenia (type 2B). Current NHLBI/ISTH guidelines recommend a vWF‑containing factor VIII concentrate (e.g., Humate‑P) for perioperative hemostasis in type 2A/2B VWD because it provides predictable amounts of functional vWF and factor VIII. Option A (DDAVP alone) is inappropriate for type 2A/2B. Option C (cryoprecipitate) has variable vWF content, carries infectious risks, and is not first‑line. Option D (platelet transfusion) does not correct the plasma vWF deficiency and is not indicated. Option E (rFVIIa) is reserved for life‑threatening bleeding refractory to standard therapy. No internal contradictions exist, and the stem supplies all necessary data to select a single best answer. Main medical accuracy issue: none; the answer aligns with contemporary VWD management. Minimal fix: none required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128", "question_id": "20251223T225810101Z_gpt-5.1-2025-11-13_seed128-020", "question": "A 34-year-old woman with bipolar I disorder is euthymic on lithium 900 mg/day and quetiapine 300 mg/night. She presents with new-onset obsessions about contamination and spends 5-6 hours/day on cleaning rituals, causing functional impairment. She has insight that these thoughts and behaviors are excessive. Thyroid and renal function are normal; she has had no manic or hypomanic symptoms for 18 months. Which of the following is the most appropriate next step in her psychiatric management?", "options": ["Add high-dose fluoxetine and maintain current mood stabilizer regimen", "Discontinue lithium and start clomipramine to target obsessive-compulsive symptoms", "Increase quetiapine dose and avoid antidepressants to prevent mood switching", "Initiate cognitive-behavioral therapy with exposure and response prevention while continuing current medications", "Switch quetiapine to risperidone, which has superior efficacy for obsessive-compulsive symptoms"], "answer": "D", "answer_index": 3, "explanation": "She has emergent OCD symptoms with stable bipolar I disorder; first-line management is CBT with exposure and response prevention, which does not risk mood destabilization. SSRIs can be considered adjunctively but carry a risk of inducing mania even with mood stabilizers. Changing antipsychotics has limited evidence for OCD, and clomipramine has higher switch risk.", "generator_model": "gpt-5.1-2025-11-13", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "kimi-k2-thinking", "judge_model_outputs_raw": "{\"analysis\":\"Validity: V (Valid). Verdict: Correct best answer. Key stem clues: bipolar I disorder euthymic for 18 months on lithium 900 mg/day and quetiapine 300 mg/night; new-onset contamination obsessions with 5-6 hours/day of cleaning rituals, preserved insight, and marked functional impairment. The clinical problem is selecting an OCD treatment that does not destabilize mood. CBT with ERP (Option D) is first-line for OCD and carries no mania risk, making it uniquely defensible in this bipolar context. Alternative critique: A (high-dose fluoxetine) poses unacceptable mood-switching risk even with mood stabilizers; B (discontinue lithium) would endanger euthymia and clomipramine has high switch potential; C (increase quetiapine) lacks evidence for OCD symptom control; E (switch to risperidone) has minimal OCD efficacy data and risks losing mood stability. No internal contradictions or underspecification. Medical accuracy: fully consistent with APA and ISBD consensus that psychotherapy is preferred initial treatment for OCD in bipolar disorder to avoid antidepressant-associated mood switching. The vignette is realistic, modern, and board-examination appropriate. Minimal fix: None required.\",\"medical_accuracy_score\":  \t\"5\",\"logical_validity\": true,\"logical_false_reason\": \"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity: V (Valid). Verdict: Correct best answer. Key stem clues: bipolar I disorder euthymic for 18 months on lithium 900 mg/day and quetiapine 300 mg/night; new-onset contamination obsessions with 5-6 hours/day of cleaning rituals, preserved insight, and marked functional impairment. The clinical problem is selecting an OCD treatment that does not destabilize mood. CBT with ERP (Option D) is first-line for OCD and carries no mania risk, making it uniquely defensible in this bipolar context. Alternative critique: A (high-dose fluoxetine) poses unacceptable mood-switching risk even with mood stabilizers; B (discontinue lithium) would endanger euthymia and clomipramine has high switch potential; C (increase quetiapine) lacks evidence for OCD symptom control; E (switch to risperidone) has minimal OCD efficacy data and risks losing mood stability. No internal contradictions or underspecification. Medical accuracy: fully consistent with APA and ISBD consensus that psychotherapy is preferred initial treatment for OCD in bipolar disorder to avoid antidepressant-associated mood switching. The vignette is realistic, modern, and board-examination appropriate. Minimal fix: None required.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]